| Financial Year |
March 31 2023 |
| Monetary Funds |
543,777,749.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
63,619,107.07 |
| Accounts Receivable |
702,530,365.18 |
| Advances to Suppliers |
54,348,222.29 |
| Other Receivables |
16,081,611.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,495,277,847.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
211,281,472.31 |
| Other Current Assets |
158,909,457.95 |
| Total Current Assets |
3,458,063,974.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
92,917,930.82 |
| Long-term Equity Investment |
399,325,611.05 |
| Investment Properties |
-- |
| Fixed Assetes |
1,033,662,846.32 |
| Under-construction Projects |
151,458,801.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
360,445,919.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
48,604,644.82 |
| Deferred Income Tax Assets |
39,778,886.12 |
| Other Non-Current Assets |
20,070,346.65 |
| Sub-Total of Non-Current Assets |
2,159,417,813.78 |
| Total Assets |
5,617,481,788.69 |
| Short-Term Loans |
89,053,135.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
563,150,950.40 |
| Accounts Payable |
432,003,131.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,303,544.20 |
| Taxes Payable |
25,303,453.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
55,747,440.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
106,551,954.68 |
| Other Current Liabilities |
100,995,176.37 |
| Sub-Total of Current Liabilities |
1,891,967,885.98 |
| Long-term Loans |
1,018,429,037.92 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
61,625,589.93 |
| Deferred Income Tax Liabilities |
14,038,335.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,206,525,403.15 |
| Total Liabilities |
3,098,493,289.13 |
| Paid-In Capital(Or Share Stock) |
468,607,084.00 |
| Capital Surplus |
202,423,949.75 |
| Surplus Reserve |
155,620,025.72 |
| LESS:Treasury Stock |
14,330,544.90 |
| Undistributed Profits |
1,647,189,041.36 |
| Minority Stockholder's Interest |
57,324,468.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,461,664,031.23 |
| Owner's Equity（Stockholder's Equity） |
2,518,988,499.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,617,481,788.69 |
